Journal of Clinical Oncology and Cancer Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Research Article - Journal of Clinical Oncology and Cancer Research (2019) Volume 2, Issue 1

Association of high expression of non-coding RNA FLJ22447 with HIF-1a in ESCC patients.

Background: This study investigated the prognostic values of hypoxia-regulated markers and their interrelationships in esophageal cancer patients. Methods: Fresh tumor and margin normal tissue specimens were obtained from 49 patients with esophageal cancer (Age: 48 years; range: 29 to 81 years). Samples collected from the Tumor Bank of Cancer Institute, Imam Khomeini Hospital in 2016-2017. The Quantitative real-time PCR was performed to determine the expression level of HIF-1a, VEGFA, and FLJ22447 and correlated with demographic information of patients, tumor characteristics, and survival. Results: Significant up-regulation of HIF-1a, VEGFA, and FLJ22447 were observed in ESCC tumor tissues than normal tissues. High expression of VEGFA was associated with advanced stages (III-IV) and metastasis, while HIF-1a correlated with I-II stage. Moreover, high tumor HIF-1a expression was associated with reduced overall survival of ESCC patients. Conclusions: The evidence from this study suggests that hypoxia-driven angiogenesis by up-regulation of HIF-1a and FLJ22447 in tumor tissues may play a crucial role in ESCC progression. Measuring FLJ22447 expression extends our knowledge to enhance our understanding about its regulatory function on HIF-1a and subsequently angiogenesis by VEGFA.

Author(s): Shabbou Bahramian, Reza Sahebi, Zahra Roohinejad, Encieh Delshad, Naeme Javid, Amirnader Emami Razavi, Mohammad Shafiee, Fatemeh T Shamsabadi

Abstract Full Text PDF

Get the App